ABSTRACT
Recognizing the urgent need for an up-to-date review of new and innovative research on growth hormone (GH) secretagogues, this exclusive work furnishes the state of the art on the mechanisms of action, design, synthesis, evaluation, and clinical applications of GH secretagogues, including orally active and xenobiotic GH-releasing compounds.
Beg
TABLE OF CONTENTS
chapter |10 pages
Requirements of Growth Hormone Secretagogues
of growth hormone-releasing peptides (GHRPs), progenitors
chapter 6|12 pages
Evidence for
Receptors in Ovine Pituitary Gland of the first potent hexapeptide growth hormone-releasing
chapter 7|14 pages
The Design, Synthesis, and Biological
Activities of Tetrahydroquinoline- lsoindoline- Based Growth Hormone Secretagogues
chapter 8|10 pages
Development of a New and Simple
Screening System for the Evaluation of Growth Hormone Secretagogues
chapter 9|14 pages
Agonistic Analogs of Growth Hormone-Releasing Hormone: Endocrine and Growth Studies
Growth
chapter 11|10 pages
Clinical Evidence for Extrahypophysea1 Action Site of Growth Hormone Secretagogues
Action
chapter 14|12 pages
Anterior Pituitary Function in Prolonged Continuous Hormone Secretagogues
Critical Illness: Effects of Infusion of Growth
chapter 15|10 pages
Hepatic Extraction of Hexarelin,
Peptidic Growth Hormone Secretagogue, the Isolated Perfused Rat Liver
chapter 17|14 pages
Immunocytochemical Studies Investigating Central Actions of the Nonpeptidyl Hormone Secretagogue,
Growth
chapter 18|14 pages
Neurochemical Identification of the Cells Expressing e-tas mRNA in the Rat Arcuate Nucleus Following Systemic Hormone-Releasing Peptide-6
Growth Injection
chapter |24 pages
Use of Growth Hormone Secretagogues
of interest in clinical uses for growth hormone (GH) has largely
chapter 25|10 pages
Reproducibility of the Growth Hormone Response to Hexarelin in Children and the Effect of Sex Steroids
the Effect of
chapter |10 pages
Interferon-a Is Able to Reduce Growth Hormone Response to
Patients with Active Chronic Hepatitis: Preliminary Data
chapter 28|10 pages
Growth Hormone-Releasing Effect of Hexarelin, a Synthetic GHRP, and GHRH in
Children and Adults with Down Syndrome